Skip to main content
Equibles
IRME logo

IRME · IR-Med, Inc.

Track IRME — free

Use IRME with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IRME.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.00 At close · Jul 24
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2025

Substantial doubt about the company's ability to continue as a going concern.

“For the six months ended June 30, 2025, and as of the date of this report, we assessed our financial condition and concluded that based on our current and projected cash resources and commitments, as well as other factors mentioned above, there is a substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2025
Market Cap
$162,201
Shares
77.24M
Volume · Jul 24 2100 Avg daily vol (2 sessions) 3050

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.00 Open$0.00 Day$0.00–0.00 52W close$0.00–0.05 Avg vol 30d27K Short int16K · 0.0% float · 1.0d Short vol34% DataJan 2021–Jul 2026 Filing10-Q · Aug 14

Up next

Latest filing: 10-Q
filed Aug 14, 2025

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$2.35M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+4.9%
Year over year · more shares
Price change (1Y)
-91.5%
Trailing year
Short interest
—
Latest settlement
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Bearish Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 17.3 · elevated Equity put/call 0.56
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −100%
below
Price vs 50-day avg −94%
below
RSI (14) 36
neutral
MACD trend Negative
52-week position 2%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −96%
trailing
6-month return −100%
trailing
YTD return −93%
this year
Relative strength −107%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.02% of float · ▲ +13252.1% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Fair
EPS growth +57%
Y/Y
Free cash flow $-1.4M
Balance sheet $28.0K
net debt
Quant / Vol
risk profile
Very High
Volatility 587%
annualized · 1-yr
Max drawdown −100%
past year
ATR 319.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
4 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−100% Bearish
Price vs 50-day avg
−94% Bearish
RSI (14)
36 Neutral
MACD trend
Negative Bearish
52-week position
2% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.02% of float · ▲ +13252.1% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 2% Range high $0
vs 200-day avg -100% vs 50-day avg -94%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
IRME
IR-Med, Inc.
this stock
$162,201 -93.0% — — 0.0%
ABT
Abbott Laboratories
 $179.20B -18.2% +5.7% 33.3 0.8%
MDT
Medtronic plc
 $121.04B -1.5% +8.4% 23.3 3.1%
SYK
Stryker Corp
 $116.76B -13.4% +11.2% 31.5 1.5%
BSX
Boston Scientific Corp
 $66.02B -52.2% +12.5% 18.4 2.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
15.9K
Days to cover
1.0d
Change
+15.8K sh
View
Short Volume
Short vol %
34%
As of
Jan 26, 2026
Short Total
View
Fails to Deliver
FTD shares
593
Value
$30
As of
Jan 6, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Jul 20, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-1.9M
EPS diluted
$-0.03
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 15, 2026
This year
3
View
Exempt Offerings
Offering
$5.0M
Filed
Apr 26, 2022
View

Performance

5D 20D 120D MTD YTD
IRME -32.3% -95.8% -99.8% -70.0% -93.0%
SPY -0.6% +0.6% +6.8% -1.1% +8.4%
vs SPY -31.7% -96.4% -106.5% -69.0% -101.4%
Key facts CIK 1839133 Visit website